Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Peter W. T. Pisters is active.

Publication


Featured researches published by Peter W. T. Pisters.


Cancer | 2003

Prognostic factors for patients with localized soft-tissue sarcoma treated with conservation surgery and radiation therapy: an analysis of 1225 patients.

Gunar K. Zagars; Matthew T. Ballo; Peter W. T. Pisters; Raphael E. Pollock; Shreyaskumar R. Patel; Robert S. Benjamin; Harry L. Evans

Prognostic factors for patients with soft‐tissue sarcoma who are treated with conservative surgery and radiation are documented poorly.


Cancer | 2000

Primary treatment of cystosarcoma phyllodes of the breast

Arthur W. Chaney; Alan Pollack; Marsha D. McNeese; Gunar K. Zagars; Peter W. T. Pisters; Raphael E. Pollock; Kelly K. Hunt

Cystosarcoma phyllodes is a rare sarcoma of the breast. Although surgical removal is the mainstay of treatment, the extent of surgery required (excision vs. mastectomy) and the need for additional local therapy, such as radiotherapy, are unclear. The current study evaluated the rate of local and distant failure, as well as potential prognostic factors, to better define appropriate treatment strategies.


Cancer | 2002

CPT-11 plus cisplatin in patients with advanced, untreated gastric or gastroesophageal junction carcinoma: results of a phase II study.

Jaffer A. Ajani; R N Jackie Baker; Peter W. T. Pisters; Linus Ho; Paul F. Mansfield; Barry W. Feig; Chusilp Charnsangavej

This Phase II study assessed the response rate and toxicity profile of the combination CPT‐11 and cisplatin administered weekly to patients with untreated, advanced adenocarcinoma of the stomach or the gastroesophageal junction.


Cancer | 2003

Surgical margins and reresection in the management of patients with soft tissue sarcoma using conservative surgery and radiation therapy.

Gunar K. Zagars; Matthew T. Ballo; Peter W. T. Pisters; Raphael E. Pollock; Shreyaskumar R. Patel; Robert S. Benjamin

Patients with localized soft tissue sarcoma (STS) who present to specialist centers after undergoing apparent macroscopic total resection often have a significant incidence of residual tumor and may benefit from reresection of the tumor bed. The potential benefits of such reresection have not been documented adequately.


Cancer | 2001

A three-step strategy of induction chemotherapy then chemoradiation followed by surgery in patients with potentially resectable carcinoma of the esophagus or gastroesophageal junction

Jaffer A. Ajani; Ritsuko Komaki; Joe B. Putnam; Garrett Walsh; Jon Nesbitt; Peter W. T. Pisters; Patrick M. Lynch; Ara Vaporciyan; Roy Smythe; Sandeep Lahoti; Issac Raijman; Stephen Swisher; D R N Faye Martin; Jack A. Roth

Patients with locoregional carcinoma of the esophagus or gastroesophageal junction have a poor survival rate after surgery. Preoperative chemotherapy or chemoradiotherapy has not improved the outcome for these patients. Our study was designed to assess the feasibility of preoperative induction combination chemotherapy in addition to chemoradiotherapy to improve the curative resection rate, local control, and survival.


Cancer | 2002

Radiographic response to neoadjuvant chemotherapy is a predictor of local control and survival in soft tissue sarcomas

Funda Meric; Kenneth R. Hess; Datla G. K. Varma; Kelly K. Hunt; Peter W. T. Pisters; Kresimira M. Milas; Shreyaskumar R. Patel; Robert S. Benjamin; Carl Plager; Nicholas E. Papadopoulos; Michael A. Burgess; Raphael E. Pollock; Barry W. Feig

Downstaging of large soft tissue sarcomas can be accomplished by the use of neoadjuvant chemotherapy (NeoCT). The authors tested the hypothesis that radiographic response to NeoCT predicts improved local control and survival.


Cancer | 1999

Patterns of recurrence in extremity liposarcoma: Implications for staging and follow-up

David B. Pearlstone; Peter W. T. Pisters; Richard J. Bold; Barry W. Feig; Kelly K. Hunt; Alan W. Yasko; Shreyaskumar Patel; Alan Pollack; Robert S. Benjamin; Raphael E. Pollock

Liposarcoma is one of the most common histologic types of soft tissue sarcoma and presents a wide spectrum of clinical behavior. The authors examined the correlation among histologic subtypes, outcomes, and patterns of recurrence among patients with extremity liposarcomas.


Cancer | 2002

Surgical management of soft tissue sarcomas of the hand and foot

Patrick P. Lin; Volkan B. Guzel; Peter W. T. Pisters; Gunar K. Zagars; Kristin L. Weber; Barry W. Feig; Raphael E. Pollock; Alan W. Yasko

Soft tissue sarcomas of the hand and foot present unique management challenges. The purpose of the current study study was to determine oncologic outcome, particularly with respect to factors affecting local recurrence, distant recurrence, and disease‐specific survival.


Cancer | 2001

Utility of chest computed tomography for staging in patients with T1 extremity soft tissue sarcomas

Jason B. Fleming; Scott B. Cantor; Datla G. K. Varma; Daniel Holst; Barry W. Feig; Kelly K. Hunt; Shreyaskumar R. Patel; Robert S. Benjamin; Raphael E. Pollock; Peter W. T. Pisters

National Cancer Center Network (NCCN) and Society of Surgical Oncology (SSO) practice guidelines recommend chest computed tomography (CT) as part of the staging evaluation of patients with extremity soft tissue sarcoma (STS). In the current study, the authors evaluated the use and yield of chest roentgenography (CXR) and selective chest CT to screen for pulmonary metastases in patients with T1 STS.


Cancer | 2002

Cost-effectiveness of staging computed tomography of the chest in patients with T2 soft tissue sarcomas.

Geoffrey A. Porter; Scott B. Cantor; Syed A. Ahmad; Jeffrey T. Lenert; Matthew T. Ballo; Kelly K. Hunt; Barry W. Feig; Shreyaskumar R. Patel; Robert S. Benjamin; Raphael E. Pollock; Peter W. T. Pisters

Published practice guidelines recommend routine chest computed tomography (CT) scanning as part of the staging evaluation for patients with T2 soft tissue sarcomas (STS), although there is no direct evidence to support this practice. The objective of this study was to determine the yield and cost‐effectiveness of routine versus selective chest CT scanning for the staging of patients with T2 STS and to identify any subgroups for whom a more selective approach to chest CT scanning could be considered.

Collaboration


Dive into the Peter W. T. Pisters's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Barry W. Feig

University of Texas MD Anderson Cancer Center

View shared research outputs
Top Co-Authors

Avatar

Robert S. Benjamin

University of Texas MD Anderson Cancer Center

View shared research outputs
Top Co-Authors

Avatar

Kelly K. Hunt

University of Texas MD Anderson Cancer Center

View shared research outputs
Top Co-Authors

Avatar

Gunar K. Zagars

University of Texas MD Anderson Cancer Center

View shared research outputs
Top Co-Authors

Avatar

Matthew T. Ballo

University of Texas MD Anderson Cancer Center

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Alan W. Yasko

University of Texas MD Anderson Cancer Center

View shared research outputs
Top Co-Authors

Avatar

Jaffer A. Ajani

University of Texas MD Anderson Cancer Center

View shared research outputs
Top Co-Authors

Avatar

Michael A. Burgess

University of Texas MD Anderson Cancer Center

View shared research outputs
Researchain Logo
Decentralizing Knowledge